Eric P. Brass, M.D., Ph.D.
Harbor-UCLA Medical Center

The Balance Between Safety and Efficacy: Biomarkers as Safety Surrogates (2006)

James De Lemos, M.D.
University of Texas-Southwestern  Medical School

Biomarkers in Heart Failure (2006)

Zahi A. Fayad, Ph.D., FAHA, FACC
Mount Sinai School of Medicine

In Vivo Imaging of Atherosclerosis by Multimodality MR, CT, and PET (2006)

Timao Li, Ph.D.
Health Products and Food Branch, Health Canada

Canadian Regulatory View on Cardiovascular Biomarkers and Surrogate Endpoints in Clinical Trials (2006)

Christopher O’Donnell, M.D.
NHLBI, National Institutes of Health

NIH Cardiovascular Biomarker Initiatives (2006)

Gurvaneet Randhawa, MD, MPH
Center for Outcomes and Evidence (COE)
Agency for Healthcare Research and Quality

Integrating Biomarkers into Practice:  The Need for Data on Clinical Outcomes (2006)

Norman Stockbridge, M.D.
Center for Drug Evaluation and Research
US Food and Drug Administration

The Use of Biomarkers for FDA Regulatory Decision Making – Cardio-Renal (2006)

Jean-Claude Tardif, M.D.
Montreal Heart Institute

The Role of Imaging in Disease Detection and Treatment (2006)

Douglas C. Throckmorton, M.D.
Center for Drug Evaluation and Research
US Food and Drug Administration

The FDA Critical Path Initiative – Opportunities and Challenges (2006)

Paula Trumbo, Ph.D.
Center for Food Safety and Applied Nutrition
US Food and Drug Administration

The Use of Biomarkers for FDA Regulatory Decision Making – Health Claims (2006)